These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16112273)

  • 61. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.
    Létuvé S; Lajoie-Kadoch S; Audusseau S; Rothenberg ME; Fiset PO; Ludwig MS; Hamid Q
    J Allergy Clin Immunol; 2006 Mar; 117(3):590-6. PubMed ID: 16522458
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Receptor epitope usage by an interleukin-5 mimetic peptide.
    Ishino T; Urbina C; Bhattacharya M; Panarello D; Chaiken I
    J Biol Chem; 2005 Jun; 280(24):22951-61. PubMed ID: 15826943
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Revealing and utilizing receptor recognition mechanisms in a high-throughput world.
    Chaiken I
    J Cell Biochem Suppl; 2001; Suppl 37():126-35. PubMed ID: 11842438
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Interleukin-18].
    Fol M; Gościcka T
    Postepy Hig Med Dosw; 2003; 57(6):685-99. PubMed ID: 15002164
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines.
    Bessoles S; Fouret F; Dudal S; Besra GS; Sanchez F; Lafont V
    J Leukoc Biol; 2008 Jul; 84(1):224-33. PubMed ID: 18456817
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of a potent small molecule IL-2 inhibitor through fragment assembly.
    Braisted AC; Oslob JD; Delano WL; Hyde J; McDowell RS; Waal N; Yu C; Arkin MR; Raimundo BC
    J Am Chem Soc; 2003 Apr; 125(13):3714-5. PubMed ID: 12656598
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells.
    Hoeve MA; Savage ND; de Boer T; Langenberg DM; de Waal Malefyt R; Ottenhoff TH; Verreck FA
    Eur J Immunol; 2006 Mar; 36(3):661-70. PubMed ID: 16482511
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity.
    Koike M; Nakamura K; Furuya A; Iida A; Anazawa H; Takatsu K; Hanai N
    Hum Antibodies; 2009; 18(1-2):17-27. PubMed ID: 19478395
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
    Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structure-based rationale for interleukin 5 receptor antagonism.
    Ishino T; Harrington AE; Gopi H; Chaiken I
    Curr Pharm Des; 2008; 14(12):1231-9. PubMed ID: 18473871
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation.
    Plugariu CG; Wu SJ; Zhang W; Chaiken I
    Biochemistry; 2000 Dec; 39(48):14939-49. PubMed ID: 11101310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epitope-labeled soluble human interleukin-5 (IL-5) receptors. Affinity cross-link labeling, IL-5 binding, and biological activity.
    Brown PM; Tagari P; Rowan KR; Yu VL; O'Neill GP; Middaugh CR; Sanyal G; Ford-Hutchinson AW; Nicholson DW
    J Biol Chem; 1995 Dec; 270(49):29236-43. PubMed ID: 7493953
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mechanistic diversity of cytokine receptor signaling across cell membranes.
    Stroud RM; Wells JA
    Sci STKE; 2004 Apr; 2004(231):re7. PubMed ID: 15126678
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomization of the receptor alpha chain recruitment epitope reveals a functional interleukin-5 with charge depletion in the CD loop.
    Wu SJ; Li J; Tsui P; Cook R; Zhang W; Hu Y; Canziani G; Chaiken I
    J Biol Chem; 1999 Jul; 274(29):20479-88. PubMed ID: 10400676
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design and synthesis of small molecule interleukin-1 receptor antagonists based on a benzene template.
    Sarabu R; Cooper JP; Cook CM; Gillespie P; Perrotta AV; Olson GL
    Drug Des Discov; 1998 May; 15(3):191-8. PubMed ID: 9689501
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling.
    Somers W; Stahl M; Seehra JS
    EMBO J; 1997 Mar; 16(5):989-97. PubMed ID: 9118960
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interleukin 18 receptor.
    Sergi B; Penttila I
    J Biol Regul Homeost Agents; 2004; 18(1):55-61. PubMed ID: 15323361
    [No Abstract]   [Full Text] [Related]  

  • 79. Asymmetric usage of antagonist charged residues drives interleukin-5 receptor recruitment but is insufficient for receptor activation.
    Ishino T; Pillalamarri U; Panarello D; Bhattacharya M; Urbina C; Horvat S; Sarkhel S; Jameson B; Chaiken I
    Biochemistry; 2006 Jan; 45(4):1106-15. PubMed ID: 16430207
    [TBL] [Abstract][Full Text] [Related]  

  • 80. On the peptide-antipeptide interactions in interleukin-1 receptor system.
    Kluczyk A; Cebrat M; Zbozień-Pacamaj R; Lisowski M; Stefanowicz P; Wieczorek Z; Siemion IZ
    Acta Biochim Pol; 2004; 51(1):57-66. PubMed ID: 15094825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.